Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature
- 30 July 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Pituitary
- Vol. 13 (4), 345-350
- https://doi.org/10.1007/s11102-010-0243-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic womenClinical Endocrinology, 2010
- High dose cabergoline therapy for a resistant macroprolactinoma during pregnancyClinical Endocrinology, 2009
- Pregnancy outcomes following cabergoline treatment: extended results from a 12‐year observational studyClinical Endocrinology, 2007
- Prevalence and Clinical Features of Epilepsy in ArgentinaNeuroepidemiology, 2006
- Epidemiological Survey of Epilepsy in the Primary School Population in Buenos AiresNeuroepidemiology, 2005
- Hyperprolactinemia: Etiology, Diagnosis, and ManagementSeminars in Reproductive Medicine, 2002
- Maternal age and fetal loss: population based register linkage studyBMJ, 2000
- Cabergoline treatment for a large macroprolactinoma throughout pregnancyJournal of Obstetrics and Gynaecology, 1997
- Pregnancy outcome after treatment with the ergot derivative, cabergolineReproductive Toxicology, 1996
- Cabergoline treated hyperprolactinaemia results in pregnancy in a bromocriptine intolerant patient after seventeen years of infertilityBJOG: An International Journal of Obstetrics and Gynaecology, 1994